Profits up at Bluefin as revenues remain flat
Bluefin has reported a 10% increase in Ebitda to £25m for 2013 from £22.7m the year before.
The increase came despite revenues remaining static at £100m.
The commercial broking arm, which represents 90% of Bluefin's income, grew operating profits by approximately 15% over the year while the firm defined personal lines business as remaining "challenging in an extremely competitive market".
The broker also reported that operating expenses dropped by £2.7m to £75m for the year, a 3.5% decrease on the previous 12 months.
Mike Bruce, CEO of Bluefin, said: "A number of important developments
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact info@insuranceage.co.uk.
You are currently unable to print this content. Please contact info@insuranceage.co.uk to find out more.
You are currently unable to copy this content. Please contact info@insuranceage.co.uk to find out more.
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. Printing this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/
If you would like to purchase additional rights please email info@insuranceage.co.uk
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. Copying this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/
If you would like to purchase additional rights please email info@insuranceage.co.uk
Most read
- Aviva’s Blanc: UK insurance industry needs to start planning for a post-Flood Re world
- Home insurance prices surge a record 41.6% in a year
- FCA cancels Northern Ireland broker’s regulatory permission